The results revealed that the expression of E-cadherin and β-catenin in ovarian cancer stem cells was significantly lower than that in the HO-8910 cancer cell line, whereas the expression of N-cadherin, vimentin and fibronectin in ovarian cancer stem cells was significantly higher than that in the HO-8910 cells. The gene discussed is CDH2; the disease is cancer.